NOWDiagnostics, Inc.
Springdale, Arkansas, United States · Biotechnology, Healthcare, Health Care · 37 employees
NOWDiagnostics (NOWDx) develops and manufactures 'Touch to Test' over-the-counter and point of care diagnostic tests that yield results in minutes. It is committed to changing healthcare by providing accessible, affordable, and accurate testing for all.
Funding history
- Series series b — $22.5M — Jul 2024
- Funding Round — $19.0M — Dec 2019
- Funding Round — $13.3M — Jul 2018
- Funding Round — $10.9M — Jul 2016
Recent signals
- May 28, 2026: NOWDiagnostics Appoints Lisa A. Nibauer as Chief Executive Officer
- Jan 22, 2025: Launched NOWDiagnostics Launches First To Know® Syphilis Test Through TakeMeHome Initiative to Combat Syphilis Epidemic
- Jan 22, 2025: NOWDx Partners with NASTAD and BHOC for the TakeMeHome Initiative
- Oct 16, 2024: NOWDiagnostics and Labcorp Collaborate to Expand Access to FDA-Authorized Syphilis Test in the U.S.
- Jul 09, 2024: Raised $22.5M in Series series b
- Mar 14, 2024: NOWDiagnostics Appoints Jody Douglas Berry as Chief Scientific Officer
- Dec 20, 2019: Raised $19.0M
- Jul 09, 2018: Raised $13.3M
See plans & pricing → Track NOWDiagnostics, Inc.’s funding, hiring, and signals — with verified contacts — on Fundz.